Intimation 2020-21
- Change in Directorate
- Clarification on Price Movement
- Appointment of Secretarial Auditor
- Appointment of Statutory Auditor
- Disclosure from Mrs. Vipula J. Choksi
- Grant of Tigecycline Patent by Euracian Patent Office
- Intimation of AGM Book Closure
- Intimation of Amalgamation of Scheme approval by NCLT Ahmedabad
- Intimation of Amalgamation of Scheme approval by NCLT Mumbai
- Intimation of approval of Scheme of Arrangement
- Intimation of no adverse observation letters
- Investor Presentation
- Resignation of Statutory Auditor
- Updates
- Updation on Amalagamation
- Updation on Amalgamation
Intimation 2023-24
- Press Release – DCGI nod for Dalbavancin API and formulation
- Press Release – GMP Certificate from ANVISA, Brazil
- Press Release – Approval from NMPA, China for Prilocaine API
- Clarification on Increase in volume of security
- Press Release – Approval of TGA, Australia and Anvisa, Brazil for Parecoxib 40mg injection
- Intimation of Grant of Patent
- Intimation of Grant of Patent of Addition
- Intimation of Grant of Patent
Intimation 2024-25
- Intimation of demise of Mr. Shrirang Vaidya, Independent Director
- Intimation of retirement of Mrs. Hemal Desai, Head ‐ Taxation
- Clarification on Increase in Volume of Security
- Intimation under Reg 39(3) of SEBI (LODR) Regulation, 2015
- Intimation under Reg 39(3) of SEBI (LODR) Regulation, 2015
- Intimation under Reg 39(3) of SEBI (LODR) Regulation, 2015